Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

NCT04189276 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B Virus (HBV)

Interventions

BIOLOGICAL: ETV/TDF+T101 No.1
BIOLOGICAL: ETV/TDF+T101 No.2
BIOLOGICAL: ETV or TDF
BIOLOGICAL: ETV/TDF+Peg-IFNα-2b

Sponsor

Tasly Tianjin Biopharmaceutical Co., Ltd.